Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.92 per share. |
03 Mar 2025 |
500 |
7,878
(0%)
|
0%
|
3.9 |
1,960
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 3.92 per share. |
03 Mar 2025 |
921 |
18,327
(0%)
|
0%
|
3.9 |
3,610
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 3.92 per share. |
03 Mar 2025 |
584 |
7,610
(0%)
|
0%
|
3.9 |
2,289
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2025 |
763 |
19,248
(0%)
|
0%
|
|
0
|
Common Stock |
Joseph Vittiglio
|
Chief Business & Legal Officer |
Sale of securities on an exchange or to another person at price $ 7.39 per share. |
03 Feb 2025 |
238 |
4,501
(0%)
|
0%
|
7.4 |
1,759
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 7.39 per share. |
03 Feb 2025 |
122 |
8,378
(0%)
|
0%
|
7.4 |
902
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 7.40 per share. |
03 Feb 2025 |
86 |
18,485
(0%)
|
0%
|
7.4 |
636
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 7.39 per share. |
03 Feb 2025 |
64 |
8,194
(0%)
|
0%
|
7.4 |
473
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 9.24 per share. |
06 Jan 2025 |
140 |
18,571
(0%)
|
0%
|
9.2 |
1,294
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 9.26 per share. |
06 Jan 2025 |
19 |
8,257
(0%)
|
0%
|
9.3 |
176
|
Common Stock |
Colvin Richard A.
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.42 per share. |
10 Dec 2024 |
2,824 |
165,544
(0%)
|
0%
|
0.4 |
1,178
|
Common Stock |
Obenshain Andrew
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 0.42 per share. |
10 Dec 2024 |
971 |
374,247
(0%)
|
0%
|
0.4 |
405
|
Common Stock |
Nick Leschly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
315,839
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
49,941
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
51,364
(0%)
|
0%
|
|
0
|
Common Stock |
Richard Paulson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
Richard Paulson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
29,563
(0%)
|
0%
|
|
0
|
Common Stock |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
47,156
(0%)
|
0%
|
|
0
|
Common Stock |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
48,160
(0%)
|
0%
|
|
0
|
Common Stock |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
24,900 |
43,462
(0%)
|
0%
|
|
0
|
Common Stock |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Nov 2024 |
49,850 |
49,850
|
-
|
|
-
|
Stock Option (right to buy) |
Joseph Vittiglio
|
Chief Business & Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
50,000 |
94,783
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
50,000 |
171,006
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 0.53 per share. |
30 Sep 2024 |
1,006 |
170,000
(0%)
|
0%
|
0.5 |
529
|
Common Stock |
O. James Sterling
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
100,000 |
100,000
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 0.53 per share. |
30 Sep 2024 |
34,780 |
375,218
(0%)
|
0%
|
0.5 |
18,270
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
130,000 |
409,998
(0%)
|
0%
|
|
0
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
50,000 |
168,368
(0%)
|
0%
|
|
0
|
Common Stock |
O. James Sterling
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
300,000 |
300,000
|
-
|
|
-
|
Stock Options (Right to buy) |
Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 0.97 per share. |
03 Jun 2024 |
3,834 |
121,006
(0%)
|
0%
|
1.0 |
3,726
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 1.53 per share. |
01 Mar 2024 |
4,573 |
124,840
(0%)
|
0%
|
1.5 |
6,986
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
199,000 |
199,000
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
650,000 |
650,000
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 1.53 per share. |
01 Mar 2024 |
6,095 |
279,998
(0%)
|
0%
|
1.5 |
9,311
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
199,000 |
199,000
|
-
|
|
-
|
Stock Option (right to buy) |
Richard A. Colvin
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 1.53 per share. |
01 Mar 2024 |
6,770 |
118,368
(0%)
|
0%
|
1.5 |
10,342
|
Common Stock |
Christopher Krawtschuk
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
199,000 |
199,000
|
-
|
|
-
|
Stock Option (right to buy) |
Joseph Vittiglio
|
Chief Business & Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
199,000 |
199,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 0.90 per share. |
05 Feb 2024 |
2,714 |
129,413
(0%)
|
0%
|
0.9 |
2,449
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 0.90 per share. |
05 Feb 2024 |
1,879 |
286,093
(0%)
|
0%
|
0.9 |
1,696
|
Common Stock |
Joseph Vittiglio
|
Chief Business & Legal Officer |
Sale of securities on an exchange or to another person at price $ 0.90 per share. |
05 Feb 2024 |
5,217 |
44,783
(0%)
|
0%
|
0.9 |
4,708
|
Common Stock |
Richard Colvin A.
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
05 Jan 2024 |
597 |
125,138
(0%)
|
0%
|
1.4 |
845
|
Common Stock |
Obenshain Andrew
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 1.43 per share. |
05 Jan 2024 |
3,162 |
287,972
(0%)
|
0%
|
1.4 |
4,520
|
Common Stock |
Christopher Krawtschuk
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 4.52 per share. |
06 Dec 2023 |
4,526 |
45,474
(0%)
|
0%
|
4.5 |
20,437
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 3.54 per share. |
10 Aug 2023 |
16,929 |
291,941
(0%)
|
0%
|
3.5 |
59,956
|
Common Stock |
Nick Leschly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
10,790 |
290,939
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
21,600 |
21,600
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
21,600 |
21,600
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
10,790 |
25,041
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
10,790 |
26,464
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
21,600 |
21,600
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
21,600 |
21,600
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
10,790 |
22,256
(0%)
|
0%
|
|
0
|
Common Stock |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
10,790 |
23,260
(0%)
|
0%
|
|
0
|
Common Stock |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
21,600 |
21,600
|
-
|
|
-
|
Stock Option (right to buy) |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
21,600 |
21,600
|
-
|
|
-
|
Stock Option (right to buy) |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jun 2023 |
10,790 |
18,562
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.50 per share. |
02 Jun 2023 |
4,130 |
133,049
(0%)
|
0%
|
3.5 |
14,451
|
Common Stock |
Richard Paulson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options (Right to buy) |
Richard Paulson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
4,663 |
4,663
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
110,000 |
110,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
55,000 |
137,179
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
67,600 |
308,870
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
338,000 |
338,000
|
-
|
|
-
|
Stock Option (right to buy) |
Richard A. Colvin
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
110,000 |
110,000
|
-
|
|
-
|
Stock Option (right to buy) |
Richard A. Colvin
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
55,000 |
128,078
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. |
01 Feb 2023 |
2,260 |
82,179
(0%)
|
0%
|
6.4 |
14,419
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. |
01 Feb 2023 |
1,420 |
241,270
(0%)
|
0%
|
6.4 |
9,060
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. |
01 Feb 2023 |
1,153 |
73,078
(0%)
|
0%
|
6.4 |
7,356
|
Common Stock |
Nick Leschly
|
Director |
Sale of securities on an exchange or to another person at price $ 7.80 per share. |
11 Jan 2023 |
4,290 |
280,149
(0%)
|
0%
|
7.8 |
33,480
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 7.80 per share. |
11 Jan 2023 |
3,178 |
242,690
(0%)
|
0%
|
7.8 |
24,802
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 7.80 per share. |
11 Jan 2023 |
557 |
74,231
(0%)
|
0%
|
7.8 |
4,347
|
Common Stock |
Christopher Krawtschuk
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Dec 2022 |
100,000 |
100,000
|
-
|
|
-
|
Stock Options (Right to buy) |
Christopher Krawtschuk
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Dec 2022 |
50,000 |
50,000
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 6.41 per share. |
04 Nov 2022 |
1,263 |
245,868
(0%)
|
0%
|
6.4 |
8,101
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 6.41 per share. |
04 Nov 2022 |
218 |
74,788
(0%)
|
0%
|
6.4 |
1,398
|
Common Stock |
Richard A. Colvin
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Nov 2022 |
60,000 |
60,000
|
-
|
|
-
|
Stock Options (Right to buy) |
Richard A. Colvin
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Nov 2022 |
30,000 |
75,006
(0%)
|
0%
|
|
0
|
Common Stock |
Elisabeth Leiderman
|
Director |
Sale of securities on an exchange or to another person at price $ 6.46 per share. |
17 Oct 2022 |
1,004 |
11,466
(0%)
|
0%
|
6.5 |
6,490
|
Common Stock |
Thomas J. Klima
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Sep 2022 |
22,000 |
22,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Sep 2022 |
11,000 |
82,439
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Strategy & Financial Off |
Sale of securities on an exchange or to another person at price $ 5.53 per share. |
19 Aug 2022 |
14,194 |
189,546
(0%)
|
0%
|
5.5 |
78,473
|
Common Stock |
Douglas G. Cole
|
Chief Strategy & Financial Off |
Sale of securities on an exchange or to another person at price $ 4.39 per share. |
04 Aug 2022 |
7,448 |
203,740
(0%)
|
0%
|
4.4 |
32,707
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 4.39 per share. |
04 Aug 2022 |
21,805 |
247,131
(0%)
|
0%
|
4.4 |
95,754
|
Common Stock |
Anne-Virginie Eggimann
|
Chief Regulatory Officer |
Sale of securities on an exchange or to another person at price $ 4.95 per share. |
12 Jul 2022 |
1,358 |
42,252
(0%)
|
0%
|
4.9 |
6,722
|
Common Stock |
Nick Leschly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
3,109 |
284,439
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
4,353 |
14,251
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
7,000 |
7,000
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
3,109 |
15,674
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
3,109 |
12,470
(0%)
|
0%
|
|
0
|
Common Stock |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
3,109 |
12,470
(0%)
|
0%
|
|
0
|
Common Stock |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
3,109 |
7,772
(0%)
|
0%
|
|
0
|
Common Stock |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2022 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 3.07 per share. |
03 Jun 2022 |
3,753 |
71,439
(0%)
|
0%
|
3.1 |
11,535
|
Common Stock |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2022 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options (Right to buy) |
Charlotte Jones-Burton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2022 |
4,663 |
4,663
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
25,000 |
211,188
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
Gina Consylman
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
25,000 |
125,385
(0%)
|
0%
|
|
0
|
Common Stock |
Gina Consylman
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
25,000 |
75,192
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
18,000 |
268,936
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
90,000 |
90,000
|
-
|
|
-
|
Stock Option (right to buy) |
Anne-Virginie Eggimann
|
Chief Regulatory Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
34,000 |
34,000
|
-
|
|
-
|
Stock Option (right to buy) |
Anne-Virginie Eggimann
|
Chief Regulatory Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
17,000 |
43,610
(0%)
|
0%
|
|
0
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
15,000 |
15,000
|
-
|
|
-
|
Stock Option (right to buy) |
Jessica Whitten
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2022 |
7,500 |
56,913
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 9.40 per share. |
10 Jan 2022 |
1,584 |
189,575
(0%)
|
0%
|
9.4 |
14,893
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 9.64 per share. |
10 Jan 2022 |
3,387 |
186,188
(0%)
|
0%
|
9.6 |
32,659
|
Common Stock |
Nick Leschly
|
Director |
Sale of securities on an exchange or to another person at price $ 9.64 per share. |
10 Jan 2022 |
5,068 |
281,330
(0%)
|
0%
|
9.6 |
48,869
|
Common Stock |
Nick Leschly
|
Director |
Sale of securities on an exchange or to another person at price $ 9.40 per share. |
10 Jan 2022 |
2,369 |
286,398
(0%)
|
0%
|
9.4 |
22,274
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 9.40 per share. |
10 Jan 2022 |
2,190 |
251,379
(0%)
|
0%
|
9.4 |
20,591
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 9.64 per share. |
10 Jan 2022 |
4,683 |
246,696
(0%)
|
0%
|
9.6 |
45,156
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 9.24 per share. |
10 Jan 2022 |
852 |
253,569
(0%)
|
0%
|
9.2 |
7,876
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 9.64 per share. |
10 Jan 2022 |
279 |
49,413
(0%)
|
0%
|
9.6 |
2,690
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 9.40 per share. |
10 Jan 2022 |
130 |
49,692
(0%)
|
0%
|
9.4 |
1,222
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 10.44 per share. |
05 Jan 2022 |
2,984 |
49,822
(0%)
|
0%
|
10.4 |
31,143
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Dec 2021 |
9,502 |
52,806
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 10.18 per share. |
07 Dec 2021 |
832 |
254,421
(0%)
|
0%
|
10.2 |
8,469
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
27,606 |
61,599
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
6,645 |
33,993
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
64,779 |
191,159
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
64,781 |
126,380
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
1,539 |
24,271
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,077 |
27,348
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
27,500 |
55,211
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
18,000 |
17,721
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
25,000 |
24,613
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
25,000 |
24,613
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
28,500 |
28,059
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
8,938 |
8,799
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Business Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
35,000 |
34,458
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
2,092 |
23,420
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
20,000 |
19,690
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
25,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
27,000 |
26,582
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
34,000 |
33,474
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
25,000 |
24,613
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
6,200 |
6,103
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
50,000 |
49,227
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,384 |
34,127
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,323 |
26,743
(0%)
|
0%
|
|
0
|
Common Stock |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,000 |
2,953
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
6,241 |
11,894
(0%)
|
0%
|
|
0
|
Common Stock |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
26,361 |
25,953
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,500 |
7,384
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,000 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
5,000 |
10,038
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,500 |
7,384
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,000 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,000 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,000 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Gina Consylman
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
170,655 |
170,655
|
-
|
|
-
|
Stock Option (right to buy) |
Gina Consylman
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
100,385 |
100,385
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
20,000 |
19,690
|
-
|
|
-
|
Stock Option (right to buy) |
William D. Baird
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
25,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
William D. Baird
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
60,000 |
59,072
|
-
|
|
-
|
Stock Option (right to buy) |
William D. Baird
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,384 |
22,797
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,384 |
15,413
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
120,000 |
118,145
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
100,000 |
98,454
|
-
|
|
-
|
Common Stock |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
65,000 |
63,995
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
90,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
110,000 |
108,300
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
23,998 |
288,005
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
12,306 |
264,007
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,384 |
251,701
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
165,000 |
162,450
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
90,000 |
88,609
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
165,000 |
162,450
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
10,500 |
10,337
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
10,500 |
10,337
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
5,600 |
5,513
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
5,600 |
5,513
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
5,600 |
5,513
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
5,600 |
5,513
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,200 |
4,135
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
23,342 |
22,981
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,938 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,938 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,384 |
7,384
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
6,241 |
9,898
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
10,038 |
10,038
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
2,953 |
2,953
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,938 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
10,534 |
10,534
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
6,241 |
12,565
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
10,038 |
10,038
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,938 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,938 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
3,938 |
3,938
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
100,385 |
100,385
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas J. Klima
|
Chief Commercial Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
50,192 |
50,192
(0%)
|
0%
|
|
0
|
Common Stock |
Sarah Glickman
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
657 |
3,601
(0%)
|
0%
|
|
0
|
Common Stock |
William R. Sellers
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
8,000 |
7,876
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
3,000 |
2,953
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
5,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Ramy Ibrahim
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Ramy Ibrahim
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
5,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Denice M. Torres
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
5,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Denice M. Torres
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
4,500 |
4,430
|
-
|
|
-
|
Stock Option (right to buy) |
Denice M. Torres
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
1,476 |
2,726
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
10,337 |
24,367
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
586 |
10,468
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
978 |
11,446
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
2,584 |
14,030
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
30,115 |
54,482
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
200,771 |
255,253
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
18,000 |
17,721
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
9,500 |
9,353
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,950 |
7,827
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,000 |
6,891
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
21,000 |
20,674
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
30,000 |
60,230
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
200,000 |
401,543
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
11 Nov 2021 |
15,057 |
15,057
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
9,361 |
9,361
(0%)
|
0%
|
|
0
|
Common Stock |
Marcela V. Maus
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Najoh Tita-Reid
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
15,057 |
15,057
|
-
|
|
-
|
Stock Option (right to buy) |
Najoh Tita-Reid
|
Director |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
9,361 |
9,361
(0%)
|
0%
|
|
0
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
8,030 |
8,030
|
-
|
|
-
|
Stock Option (right to buy) |
Jessica Whitten
|
Chief Accounting Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
1,459 |
2,358
(0%)
|
0%
|
|
0
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
4,015 |
6,373
(0%)
|
0%
|
|
0
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
36,931 |
43,304
(0%)
|
0%
|
|
0
|
Common Stock |
Jessica Whitten
|
Chief Accounting Officer |
Other type of transaction at price $ 0.00 per share. |
11 Nov 2021 |
7,776 |
7,776
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Oct 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
Elisabeth Leiderman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Oct 2021 |
4,663 |
4,663
(0%)
|
0%
|
|
0
|
Common Stock |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Sep 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
Najoh Tita-Reid
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Sep 2021 |
4,663 |
4,663
(0%)
|
0%
|
|
0
|
Common Stock |
Marcela V. Maus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Sep 2021 |
4,663 |
4,663
(0%)
|
0%
|
|
0
|
Common Stock |
Marcela V. Maus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Sep 2021 |
7,500 |
7,500
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
32,265 |
112,453
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
32,266 |
80,188
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
33,926 |
114,682
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
33,927 |
80,756
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
33,585 |
69,114
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
33,584 |
102,698
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
51,303 |
409,299
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
51,304 |
357,996
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
100,000 |
139,597
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Aug 2021 |
200,000 |
200,000
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
3,109 |
8,762
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel S. Lynch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
4,353 |
12,312
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel S. Lynch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
7,000 |
7,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
3,109 |
6,766
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
3,109 |
9,433
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
3,109 |
6,721
(0%)
|
0%
|
|
0
|
Common Stock |
Ramy Ibrahim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Ramy Ibrahim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
3,109 |
5,359
(0%)
|
0%
|
|
0
|
Common Stock |
Denice M. Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
3,109 |
5,859
(0%)
|
0%
|
|
0
|
Common Stock |
Denice M. Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2021 |
5,000 |
5,000
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
President of SGD |
Sale of securities on an exchange or to another person at price $ 30.75 per share. |
04 Jun 2021 |
511 |
39,597
(0%)
|
0%
|
30.8 |
15,715
|
Common Stock |
Thomas J. Klima
|
Chief Commercial Officer, SGD |
Grant, award, or other acquisition of securities at price $ 31.11 per share. |
01 Jun 2021 |
25,000 |
25,000
(0%)
|
0%
|
31.1 |
777,750
|
Common Stock |
Thomas J. Klima
|
Chief Commercial Officer, SGD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jun 2021 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 May 2021 |
123,000 |
123,000
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 May 2021 |
123,000 |
45,699
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 30.16 per share. |
03 May 2021 |
38 |
47,922
(0%)
|
0%
|
30.2 |
1,146
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 30.15 per share. |
03 May 2021 |
39 |
46,829
(0%)
|
0%
|
30.2 |
1,176
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 30.15 per share. |
03 May 2021 |
444 |
306,692
(0%)
|
0%
|
30.2 |
13,387
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Sale of securities on an exchange or to another person at price $ 30.14 per share. |
03 May 2021 |
29 |
40,108
(0%)
|
0%
|
30.1 |
874
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 30.22 per share. |
05 Apr 2021 |
37 |
47,960
(0%)
|
0%
|
30.2 |
1,118
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 30.21 per share. |
05 Apr 2021 |
39 |
46,868
(0%)
|
0%
|
30.2 |
1,178
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 30.20 per share. |
05 Apr 2021 |
444 |
307,136
(0%)
|
0%
|
30.2 |
13,411
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 30.21 per share. |
05 Apr 2021 |
42 |
47,787
(0%)
|
0%
|
30.2 |
1,269
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Sale of securities on an exchange or to another person at price $ 30.21 per share. |
05 Apr 2021 |
29 |
40,137
(0%)
|
0%
|
30.2 |
876
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Mar 2021 |
203,355 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. |
04 Mar 2021 |
203,355 |
307,580
(0%)
|
0%
|
5.5 |
1,118,534
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 29.58 per share. |
02 Mar 2021 |
38 |
47,997
(0%)
|
0%
|
29.6 |
1,124
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 29.59 per share. |
02 Mar 2021 |
39 |
46,907
(0%)
|
0%
|
29.6 |
1,154
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 29.58 per share. |
02 Mar 2021 |
444 |
104,225
(0%)
|
0%
|
29.6 |
13,134
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 29.57 per share. |
02 Mar 2021 |
42 |
47,829
(0%)
|
0%
|
29.6 |
1,242
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Sale of securities on an exchange or to another person at price $ 29.59 per share. |
02 Mar 2021 |
34 |
40,166
(0%)
|
0%
|
29.6 |
1,006
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
16 Feb 2021 |
665 |
48,035
(0%)
|
0%
|
28.2 |
18,727
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
2,165 |
48,700
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
13,750 |
46,535
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
27,500 |
27,500
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
2,162 |
47,610
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
16 Feb 2021 |
664 |
46,946
(0%)
|
0%
|
28.2 |
18,699
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
25,000 |
25,000
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
12,500 |
45,448
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
16 Feb 2021 |
693 |
35,529
(0%)
|
0%
|
28.2 |
19,516
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
2,141 |
36,222
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
12,500 |
34,081
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
25,000 |
25,000
|
-
|
|
-
|
Stock Options (Right to buy) |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
90,000 |
90,000
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
18,000 |
104,669
(0%)
|
0%
|
|
0
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
16 Feb 2021 |
698 |
47,871
(0%)
|
0%
|
28.2 |
19,657
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
2,271 |
48,569
(0%)
|
0%
|
|
0
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
10,000 |
46,298
(0%)
|
0%
|
|
0
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Katy Burnett
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
1,427 |
4,615
(0%)
|
0%
|
|
0
|
Common Stock |
Katy Burnett
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
16 Feb 2021 |
518 |
4,097
(0%)
|
0%
|
28.2 |
14,588
|
Common Stock |
Katy Burnett
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
2,000 |
3,188
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
16 Feb 2021 |
749 |
40,200
(0%)
|
0%
|
28.2 |
21,093
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (right to buy) |
Andrew Obenshain
|
President of SGD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
2,065 |
40,949
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
15,000 |
38,884
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 45.52 per share. |
12 Feb 2021 |
1,216 |
21,581
(0%)
|
0%
|
45.5 |
55,352
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 45.92 per share. |
02 Feb 2021 |
38 |
32,785
(0%)
|
0%
|
45.9 |
1,745
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 45.93 per share. |
02 Feb 2021 |
59 |
32,948
(0%)
|
0%
|
45.9 |
2,710
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 45.93 per share. |
02 Feb 2021 |
594 |
86,669
(0%)
|
0%
|
45.9 |
27,280
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 45.92 per share. |
02 Feb 2021 |
63 |
36,298
(0%)
|
0%
|
45.9 |
2,893
|
Common Stock |
Andrew Obenshain
|
President of SGD |
Sale of securities on an exchange or to another person at price $ 45.91 per share. |
02 Feb 2021 |
34 |
23,884
(0%)
|
0%
|
45.9 |
1,561
|
Common Stock |
Ramy Ibrahim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2021 |
2,250 |
2,250
(0%)
|
0%
|
|
0
|
Common Stock |
Ramy Ibrahim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2021 |
4,500 |
4,500
|
-
|
|
-
|
Stock Options (Right to buy) |
William D. Baird
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 45.46 per share. |
06 Jan 2021 |
397 |
22,797
(0%)
|
0%
|
45.5 |
18,049
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 44.76 per share. |
06 Jan 2021 |
552 |
23,194
(0%)
|
0%
|
44.8 |
24,707
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 44.95 per share. |
05 Jan 2021 |
43 |
35,181
(0%)
|
0%
|
45.0 |
1,933
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 45.46 per share. |
05 Jan 2021 |
986 |
32,823
(0%)
|
0%
|
45.5 |
44,827
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 44.76 per share. |
05 Jan 2021 |
1,372 |
33,809
(0%)
|
0%
|
44.8 |
61,409
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 44.76 per share. |
05 Jan 2021 |
1,602 |
34,159
(0%)
|
0%
|
44.8 |
71,703
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 44.96 per share. |
05 Jan 2021 |
45 |
35,761
(0%)
|
0%
|
45.0 |
2,023
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 45.46 per share. |
05 Jan 2021 |
1,152 |
33,007
(0%)
|
0%
|
45.5 |
52,374
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 44.95 per share. |
05 Jan 2021 |
333 |
97,358
(0%)
|
0%
|
45.0 |
14,969
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 44.76 per share. |
05 Jan 2021 |
5,873 |
91,485
(0%)
|
0%
|
44.8 |
262,867
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 45.46 per share. |
05 Jan 2021 |
4,222 |
87,263
(0%)
|
0%
|
45.5 |
191,947
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 44.76 per share. |
05 Jan 2021 |
1,843 |
37,685
(0%)
|
0%
|
44.8 |
82,490
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 44.96 per share. |
05 Jan 2021 |
48 |
39,528
(0%)
|
0%
|
45.0 |
2,158
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 45.46 per share. |
05 Jan 2021 |
1,324 |
36,361
(0%)
|
0%
|
45.5 |
60,194
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 44.95 per share. |
05 Jan 2021 |
40 |
26,917
(0%)
|
0%
|
45.0 |
1,798
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 45.46 per share. |
05 Jan 2021 |
759 |
25,103
(0%)
|
0%
|
45.5 |
34,507
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 44.76 per share. |
05 Jan 2021 |
1,055 |
25,862
(0%)
|
0%
|
44.8 |
47,220
|
Common Stock |
Katy Burnett
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 46.09 per share. |
03 Dec 2020 |
123 |
1,460
(0%)
|
0%
|
46.1 |
5,669
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 46.19 per share. |
02 Dec 2020 |
37 |
35,225
(0%)
|
0%
|
46.2 |
1,709
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 47.00 per share. |
02 Dec 2020 |
1 |
35,224
(0%)
|
0%
|
47 |
47
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 46.50 per share. |
02 Dec 2020 |
2 |
35,806
(0%)
|
0%
|
46.5 |
93
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 46.19 per share. |
02 Dec 2020 |
57 |
35,808
(0%)
|
0%
|
46.2 |
2,633
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 46.19 per share. |
02 Dec 2020 |
430 |
97,705
(0%)
|
0%
|
46.2 |
19,861
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 46.50 per share. |
02 Dec 2020 |
14 |
97,691
(0%)
|
0%
|
46.5 |
651
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 46.50 per share. |
02 Dec 2020 |
2 |
39,576
(0%)
|
0%
|
46.5 |
93
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 46.19 per share. |
02 Dec 2020 |
62 |
39,578
(0%)
|
0%
|
46.2 |
2,864
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 46.20 per share. |
02 Dec 2020 |
35 |
26,958
(0%)
|
0%
|
46.2 |
1,617
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 47.00 per share. |
02 Dec 2020 |
1 |
26,957
(0%)
|
0%
|
47 |
47
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 53.86 per share. |
02 Nov 2020 |
7 |
35,266
(0%)
|
0%
|
53.9 |
377
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 54.50 per share. |
02 Nov 2020 |
4 |
35,262
(0%)
|
0%
|
54.5 |
218
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 52.50 per share. |
02 Nov 2020 |
26 |
35,273
(0%)
|
0%
|
52.5 |
1,365
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 52.51 per share. |
02 Nov 2020 |
43 |
35,881
(0%)
|
0%
|
52.5 |
2,258
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 54.50 per share. |
02 Nov 2020 |
6 |
35,865
(0%)
|
0%
|
54.5 |
327
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 53.80 per share. |
02 Nov 2020 |
10 |
35,871
(0%)
|
0%
|
53.8 |
538
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 54.44 per share. |
02 Nov 2020 |
45 |
98,135
(0%)
|
0%
|
54.4 |
2,450
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 52.51 per share. |
02 Nov 2020 |
319 |
98,260
(0%)
|
0%
|
52.5 |
16,750
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 53.82 per share. |
02 Nov 2020 |
80 |
98,180
(0%)
|
0%
|
53.8 |
4,306
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 54.50 per share. |
02 Nov 2020 |
6 |
39,640
(0%)
|
0%
|
54.5 |
327
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 53.83 per share. |
02 Nov 2020 |
12 |
39,646
(0%)
|
0%
|
53.8 |
646
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 52.51 per share. |
02 Nov 2020 |
45 |
39,658
(0%)
|
0%
|
52.5 |
2,363
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 54.50 per share. |
02 Nov 2020 |
4 |
26,993
(0%)
|
0%
|
54.5 |
218
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 52.50 per share. |
02 Nov 2020 |
24 |
27,004
(0%)
|
0%
|
52.5 |
1,260
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 53.86 per share. |
02 Nov 2020 |
7 |
26,997
(0%)
|
0%
|
53.9 |
377
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 52.76 per share. |
02 Oct 2020 |
38 |
35,299
(0%)
|
0%
|
52.8 |
2,005
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 52.77 per share. |
02 Oct 2020 |
60 |
35,924
(0%)
|
0%
|
52.8 |
3,166
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 52.76 per share. |
02 Oct 2020 |
450 |
98,579
(0%)
|
0%
|
52.8 |
23,744
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 52.77 per share. |
02 Oct 2020 |
64 |
39,703
(0%)
|
0%
|
52.8 |
3,377
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 52.78 per share. |
02 Oct 2020 |
36 |
27,028
(0%)
|
0%
|
52.8 |
1,900
|
Common Stock |
Douglas G. Cole
|
Chief Operating and, Legal Officer |
Sale of securities on an exchange or to another person at price $ 58.61 per share. |
03 Sep 2020 |
36 |
35,337
(0%)
|
0%
|
58.6 |
2,110
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 58.60 per share. |
03 Sep 2020 |
58 |
35,984
(0%)
|
0%
|
58.6 |
3,399
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 58.60 per share. |
03 Sep 2020 |
431 |
99,029
(0%)
|
0%
|
58.6 |
25,257
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 58.61 per share. |
03 Sep 2020 |
41 |
39,767
(0%)
|
0%
|
58.6 |
2,403
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 58.60 per share. |
03 Sep 2020 |
35 |
27,063
(0%)
|
0%
|
58.6 |
2,051
|
Common Stock |
Denice Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Aug 2020 |
4,500 |
4,500
|
-
|
|
-
|
Stock Option (right to buy) |
Denice Torres
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Aug 2020 |
2,250 |
2,750
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Sale of securities on an exchange or to another person at price $ 60.32 per share. |
03 Aug 2020 |
28 |
35,382
(0%)
|
0%
|
60.3 |
1,689
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Sale of securities on an exchange or to another person at price $ 61.00 per share. |
03 Aug 2020 |
9 |
35,373
(0%)
|
0%
|
61 |
549
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 61.00 per share. |
03 Aug 2020 |
15 |
36,042
(0%)
|
0%
|
61 |
915
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 60.32 per share. |
03 Aug 2020 |
44 |
36,057
(0%)
|
0%
|
60.3 |
2,654
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 60.32 per share. |
03 Aug 2020 |
332 |
99,572
(0%)
|
0%
|
60.3 |
20,026
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 60.98 per share. |
03 Aug 2020 |
112 |
99,460
(0%)
|
0%
|
61.0 |
6,830
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 62.00 per share. |
03 Aug 2020 |
11 |
39,808
(0%)
|
0%
|
62 |
682
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 60.32 per share. |
03 Aug 2020 |
31 |
39,819
(0%)
|
0%
|
60.3 |
1,870
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 61.00 per share. |
03 Aug 2020 |
82 |
9,512
(0%)
|
0%
|
61 |
5,002
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 61.00 per share. |
03 Aug 2020 |
9 |
27,098
(0%)
|
0%
|
61 |
549
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 60.31 per share. |
03 Aug 2020 |
26 |
27,107
(0%)
|
0%
|
60.3 |
1,568
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 66.38 per share. |
20 Jul 2020 |
596 |
9,594
(0%)
|
0%
|
66.4 |
39,562
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Sale of securities on an exchange or to another person at price $ 61.58 per share. |
02 Jul 2020 |
38 |
35,410
(0%)
|
0%
|
61.6 |
2,340
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 61.58 per share. |
02 Jul 2020 |
59 |
36,101
(0%)
|
0%
|
61.6 |
3,633
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 61.57 per share. |
02 Jul 2020 |
443 |
99,904
(0%)
|
0%
|
61.6 |
27,277
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 61.57 per share. |
02 Jul 2020 |
42 |
39,850
(0%)
|
0%
|
61.6 |
2,586
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 61.58 per share. |
02 Jul 2020 |
36 |
27,133
(0%)
|
0%
|
61.6 |
2,217
|
Common Stock |
Wendy L. Dixon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
3,000 |
3,000
|
-
|
|
-
|
Stock Option (right to buy) |
Wendy L. Dixon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
153 |
4,153
(0%)
|
0%
|
|
0
|
Common Stock |
Wendy L. Dixon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
1,500 |
5,653
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas A. Melton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
3,000 |
3,000
|
-
|
|
-
|
Stock Option (right to buy) |
Douglas A. Melton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
1,500 |
6,324
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas A. Melton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
124 |
4,824
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel S. Lynch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
4,200 |
4,200
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel S. Lynch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
2,100 |
7,959
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel S. Lynch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
259 |
5,859
(0%)
|
0%
|
|
0
|
Common Stock |
David P. Schenkein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
1,500 |
6,832
(0%)
|
0%
|
|
0
|
Common Stock |
David P. Schenkein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
156 |
5,332
(0%)
|
0%
|
|
0
|
Common Stock |
David P. Schenkein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
3,000 |
3,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
157 |
2,157
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
1,500 |
3,657
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Vachon
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
3,000 |
3,000
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
1,500 |
6,324
(0%)
|
0%
|
|
0
|
Common Stock |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
3,000 |
3,000
|
-
|
|
-
|
Stock Option (right to buy) |
John O. Agwunobi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
124 |
4,824
(0%)
|
0%
|
|
0
|
Common Stock |
William R. Sellers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
3,000 |
3,000
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
1,500 |
3,612
(0%)
|
0%
|
|
0
|
Common Stock |
William R. Sellers
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
112 |
2,112
(0%)
|
0%
|
|
0
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 65.56 per share. |
04 Jun 2020 |
62 |
10,190
(0%)
|
0%
|
65.6 |
4,065
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 65.01 per share. |
04 Jun 2020 |
92 |
10,252
(0%)
|
0%
|
65.0 |
5,981
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Sale of securities on an exchange or to another person at price $ 64.24 per share. |
02 Jun 2020 |
29 |
35,448
(0%)
|
0%
|
64.2 |
1,863
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Sale of securities on an exchange or to another person at price $ 63.33 per share. |
02 Jun 2020 |
9 |
35,477
(0%)
|
0%
|
63.3 |
570
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 64.24 per share. |
02 Jun 2020 |
45 |
36,160
(0%)
|
0%
|
64.2 |
2,891
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 63.36 per share. |
02 Jun 2020 |
14 |
36,205
(0%)
|
0%
|
63.4 |
887
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 64.24 per share. |
02 Jun 2020 |
341 |
100,347
(0%)
|
0%
|
64.2 |
21,907
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 63.36 per share. |
02 Jun 2020 |
103 |
100,688
(0%)
|
0%
|
63.4 |
6,526
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 63.40 per share. |
02 Jun 2020 |
10 |
39,924
(0%)
|
0%
|
63.4 |
634
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 64.25 per share. |
02 Jun 2020 |
32 |
39,892
(0%)
|
0%
|
64.3 |
2,056
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 64.26 per share. |
02 Jun 2020 |
27 |
27,169
(0%)
|
0%
|
64.3 |
1,735
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 63.38 per share. |
02 Jun 2020 |
8 |
27,196
(0%)
|
0%
|
63.4 |
507
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 May 2020 |
1,437 |
35,486
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 May 2020 |
1,511 |
36,219
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 May 2020 |
11,384 |
100,791
(0%)
|
0%
|
|
0
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 May 2020 |
1,615 |
39,934
(0%)
|
0%
|
|
0
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 May 2020 |
1,361 |
27,204
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
9,000 |
34,049
(0%)
|
0%
|
|
0
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
18,000 |
18,000
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
10,000 |
34,708
(0%)
|
0%
|
|
0
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
William D. Baird
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
10,000 |
23,746
(0%)
|
0%
|
|
0
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
Nick Leschly
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
32,500 |
89,407
(0%)
|
0%
|
|
0
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
David Davidson
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
10,000 |
38,319
(0%)
|
0%
|
|
0
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
3,900 |
10,344
(0%)
|
0%
|
|
0
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
7,800 |
7,800
|
-
|
|
-
|
Stock Option (right to buy) |
Alison Cecily Finger
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
15,000 |
15,000
|
-
|
|
-
|
Stock Option (right to buy) |
Alison Cecily Finger
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Mar 2020 |
7,500 |
25,843
(0%)
|
0%
|
|
0
|
Common Stock |
William D. Baird
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 90.60 per share. |
13 Feb 2020 |
1,254 |
13,746
(0%)
|
0%
|
90.6 |
113,612
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
10 Jan 2020 |
600 |
25,308
(0%)
|
0%
|
50.5 |
30,306
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jan 2020 |
600 |
6,200
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 94.03 per share. |
10 Jan 2020 |
600 |
24,708
(0%)
|
0%
|
94.0 |
56,416
|
Common Stock |
Douglas G. Cole
|
Other, Legal Officer |
Sale of securities on an exchange or to another person at price $ 89.97 per share. |
07 Jan 2020 |
1,957 |
25,049
(0%)
|
0%
|
90.0 |
176,074
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 89.97 per share. |
07 Jan 2020 |
4,134 |
24,708
(0%)
|
0%
|
90.0 |
371,941
|
Common Stock |
Nick Leschly
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 89.97 per share. |
07 Jan 2020 |
10,163 |
56,712
(0%)
|
0%
|
90.0 |
914,377
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 89.97 per share. |
07 Jan 2020 |
3,297 |
28,319
(0%)
|
0%
|
90.0 |
296,635
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 89.97 per share. |
07 Jan 2020 |
223 |
6,308
(0%)
|
0%
|
90.0 |
20,064
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 89.97 per share. |
07 Jan 2020 |
1,049 |
18,148
(0%)
|
0%
|
90.0 |
94,380
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 86.66 per share. |
06 Jan 2020 |
250 |
28,842
(0%)
|
0%
|
86.7 |
21,665
|
Common Stock |
Alison Cecily Finger
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 84.96 per share. |
03 Jan 2020 |
517 |
19,197
(0%)
|
0%
|
85.0 |
43,924
|
Common Stock |
Kory J. Wentworth
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 92.59 per share. |
19 Dec 2019 |
397 |
6,449
(0%)
|
0%
|
92.6 |
36,758
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Dec 2019 |
1,800 |
6,800
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 94.30 per share. |
17 Dec 2019 |
1,800 |
29,092
(0%)
|
0%
|
94.3 |
169,749
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
17 Dec 2019 |
1,800 |
30,892
(0%)
|
0%
|
50.5 |
90,918
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 80.57 per share. |
05 Dec 2019 |
250 |
29,092
(0%)
|
0%
|
80.6 |
20,143
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 81.95 per share. |
05 Nov 2019 |
250 |
29,342
(0%)
|
0%
|
82.0 |
20,488
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 89.07 per share. |
07 Oct 2019 |
250 |
29,592
(0%)
|
0%
|
89.1 |
22,267
|
Common Stock |
William R. Sellers
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Sep 2019 |
8,000 |
8,000
|
-
|
|
-
|
Stock Option (right to buy) |
William R. Sellers
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Sep 2019 |
2,000 |
2,000
(0%)
|
0%
|
|
0
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 100.11 per share. |
09 Sep 2019 |
3,000 |
31,616
(0%)
|
0%
|
100.1 |
300,340
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Sep 2019 |
2,060 |
9,625
|
-
|
|
-
|
Stock Option (right to buy) |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Sep 2019 |
3,000 |
11,685
|
-
|
|
-
|
Stock Option (right to buy) |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 100.16 per share. |
09 Sep 2019 |
2,060 |
31,616
(0%)
|
0%
|
100.2 |
206,324
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
09 Sep 2019 |
2,060 |
33,676
(0%)
|
0%
|
50.5 |
104,051
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
09 Sep 2019 |
3,000 |
34,616
(0%)
|
0%
|
50.5 |
151,530
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 101.20 per share. |
05 Sep 2019 |
850 |
29,842
(0%)
|
0%
|
101.2 |
86,018
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Sep 2019 |
600 |
8,600
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
05 Sep 2019 |
600 |
30,692
(0%)
|
0%
|
50.5 |
30,306
|
Common Stock |
Jeffrey T. Walsh
|
Chief Strategy Officer |
Sale of securities on an exchange or to another person at price $ 124.00 per share. |
20 Aug 2019 |
500 |
40,921
(0%)
|
0%
|
124 |
62,000
|
Common Stock |
Jeffrey T. Walsh
|
Chief Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Aug 2019 |
500 |
9,521
|
-
|
|
-
|
Stock Option (right to buy) |
Jeffrey T. Walsh
|
Chief Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.47 per share. |
20 Aug 2019 |
500 |
41,421
(0%)
|
0%
|
24.5 |
12,235
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 124.03 per share. |
08 Aug 2019 |
950 |
30,092
(0%)
|
0%
|
124.0 |
117,824
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Aug 2019 |
700 |
25,000
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.60 per share. |
08 Aug 2019 |
700 |
31,042
(0%)
|
0%
|
75.6 |
52,920
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 118.44 per share. |
06 Aug 2019 |
400 |
31,616
(0%)
|
0%
|
118.4 |
47,376
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2019 |
5,060 |
14,685
|
-
|
|
-
|
Stock Option (right to buy) |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 117.77 per share. |
06 Aug 2019 |
900 |
32,016
(0%)
|
0%
|
117.8 |
105,995
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 116.11 per share. |
06 Aug 2019 |
800 |
32,916
(0%)
|
0%
|
116.1 |
92,886
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 115.25 per share. |
06 Aug 2019 |
2,960 |
33,716
(0%)
|
0%
|
115.2 |
341,132
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
06 Aug 2019 |
5,060 |
36,676
(0%)
|
0%
|
50.5 |
255,581
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
05 Aug 2019 |
600 |
31,192
(0%)
|
0%
|
50.5 |
30,306
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Aug 2019 |
600 |
9,200
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 118.01 per share. |
05 Aug 2019 |
100 |
30,342
(0%)
|
0%
|
118.0 |
11,801
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 116.79 per share. |
05 Aug 2019 |
750 |
30,442
(0%)
|
0%
|
116.8 |
87,592
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.60 per share. |
05 Jul 2019 |
700 |
32,392
(0%)
|
0%
|
75.6 |
52,920
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
05 Jul 2019 |
600 |
31,692
(0%)
|
0%
|
50.5 |
30,306
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Jul 2019 |
700 |
25,700
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Jul 2019 |
600 |
9,800
|
-
|
|
-
|
Stock Option (right to buy) |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 131.94 per share. |
05 Jul 2019 |
100 |
30,592
(0%)
|
0%
|
131.9 |
13,194
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 130.69 per share. |
05 Jul 2019 |
300 |
30,692
(0%)
|
0%
|
130.7 |
39,207
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 129.69 per share. |
05 Jul 2019 |
311 |
30,992
(0%)
|
0%
|
129.7 |
40,335
|
Common Stock |
Philip D. Gregory
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 128.27 per share. |
05 Jul 2019 |
1,089 |
31,303
(0%)
|
0%
|
128.3 |
139,690
|
Common Stock |
David Davidson
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.51 per share. |
05 Jul 2019 |
7,330 |
38,946
(0%)
|
0%
|
50.5 |
370,238
|
Common Stock |